Form 8-K · Current report
Sandisk 8-K, filed Oct 29, 2026
- Filed
- CIK
- 0002023554
- Accession no.
- 0001628280-26-068243
Summary
Sandisk reported fiscal first quarter 2027 revenue of $11.0 billion, up 23% sequentially, with GAAP net income of $8.1 billion ($52.60 per diluted share), and announced an eight-for-one forward stock split.
Key points
- Sandisk's fiscal Q1 2027 revenue rose 23% sequentially to $11.0 billion, with GAAP net income of $8.1 billion ($52.60 per diluted share).
- The company returned $5.0 billion to stockholders through share repurchases during the quarter.
- Sandisk announced an eight-for-one forward stock split, with a record date of Nov. 9, 2026, shares issued after market close Nov. 19, and post-split trading beginning Nov. 20 under the symbol SNDK.
- Sandisk guided fiscal Q2 2027 revenue to $12.2–$12.6 billion and non-GAAP diluted EPS to $55.00–$57.00 on a pre-split basis.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 29, 2026, Sandisk Corporation (the “Company”) announced financial results for the fiscal first quarter ended October 2, 2026. A copy of the press release making this announcement is attached hereto as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.